We are live on ! Find out more
SC

Schulhoff & Co Portfolio holdings

AUM $243M
1-Year Est. Return 17.47%
This Fund
S&P 500
This Quarter Est. Return
+3.51%
1 Year Est. Return
+17.47%
3 Year Est. Return
+42.69%
5 Year Est. Return
+58.83%
10 Year Est. Return
+178.36%
AUM
$238M
AUM Growth
+$3.32M
Cap. Flow
-$2.31M
Cap. Flow %
-0.97%
Top 10 Hldgs %
40.65%
Holding
138
New
3
Increased
34
Reduced
36
Closed
6

Top Buys

Rank Stock Value
1
CTMX icon
CytomX Therapeutics
CTMX
+$1.42M
2
PSLV icon
Sprott Physical Silver Trust
PSLV
+$566K
3
Q
Qnity Electronics Inc
Q
+$357K
4
CB icon
Chubb
CB
+$189K
5
WU icon
Western Union
WU
+$148K

Top Sells

Rank Stock Value
1
AVDL
Avadel Pharmaceuticals
AVDL
+$2.1M
2
PYXS icon
Pyxis Oncology
PYXS
+$611K
3
DD icon
DuPont de Nemours
DD
+$452K
4
SLV icon
iShares Silver Trust
SLV
+$441K
5
CTAS icon
Cintas
CTAS
+$290K

Sector Composition

Rank Sector Weight
1 Financials 21.72%
2 Consumer Staples 17.43%
3 Industrials 12.82%
4 Healthcare 12.68%
5 Technology 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PG icon
1
Procter & Gamble
PG
$349B
$22M 9.27%
153,667
-354
-0.2% -$52.2K
JPM icon
2
JPMorgan Chase
JPM
$907B
$14.5M 6.09%
44,894
-120
-0.3% -$37.2K
XOM icon
3
ExxonMobil
XOM
$611B
$9.51M 4%
78,986
-28
-0% -$3.25K
CINF icon
4
Cincinnati Financial
CINF
$28B
$8.73M 3.68%
53,459
-87
-0.2% -$14.1K
JNJ icon
5
Johnson & Johnson
JNJ
$609B
$8.69M 3.66%
41,991
-95
-0.2% -$18.8K
BRK.A icon
6
Berkshire Hathaway Class A
BRK.A
$1.06T
$8.3M 3.5%
11
– –
LMT icon
7
Lockheed Martin
LMT
$117B
$7.29M 3.07%
15,072
+5
+0% +$2.39K
ABBV icon
8
AbbVie
ABBV
$450B
$6.33M 2.66%
27,700
-30
-0.1% -$6.83K
MSFT icon
9
Microsoft
MSFT
$2.93T
$5.63M 2.37%
11,639
-162
-1% -$81.2K
CVX icon
10
Chevron
CVX
$373B
$5.59M 2.35%
36,680
-253
-0.7% -$38.5K
KO icon
11
Coca-Cola
KO
$351B
$5.35M 2.25%
76,592
+32
+0% +$2.23K
LLY icon
12
Eli Lilly
LLY
$1.05T
$5.21M 2.19%
4,850
+8
+0.2% +$7.65K
AAPL icon
13
Apple
AAPL
$4.9T
$5.15M 2.17%
18,940
+4
+0% +$1.07K
USB icon
14
US Bancorp
USB
$98.4B
$4.97M 2.09%
93,168
-850
-0.9% -$41.8K
GOOGL icon
15
Alphabet (Google) Class A
GOOGL
$4.23T
$4.74M 1.99%
15,137
+44
+0.3% +$12.6K
GD icon
16
General Dynamics
GD
$99.7B
$3.8M 1.6%
11,277
+2
+0% +$682
MAA icon
17
Mid-America Apartment Communities
MAA
$15.5B
$3.38M 1.42%
24,317
– –
PEP icon
18
PepsiCo
PEP
$187B
$3.13M 1.32%
21,824
-120
-0.5% -$17.6K
ACN icon
19
Accenture
ACN
$87.9B
$3.09M 1.3%
11,532
-341
-3% -$86.6K
IBM icon
20
IBM
IBM
$200B
$3.09M 1.3%
10,424
– –
GS icon
21
Goldman Sachs
GS
$314B
$3.02M 1.27%
3,437
– –
EMR icon
22
Emerson Electric
EMR
$78.2B
$2.95M 1.24%
22,205
+2
+0% +$265
QCOM icon
23
Qualcomm
QCOM
$181B
$2.5M 1.05%
14,615
– –
PNC icon
24
PNC Financial Services
PNC
$101B
$2.43M 1.02%
11,631
+2
+0% +$386
CSCO icon
25
Cisco
CSCO
$441B
$2.39M 1.01%
31,051
– –
1
2 3 4 5

Similar funds

HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
YP
YANKCOM Partnership Yankton, South Dakota $243M AUM 21.59% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
QHA
Quarry Hill Advisors St Paul, Minnesota $243M AUM 24.02% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
BB
Burford Brothers Dallas, Texas $244M AUM 24.94% 1-Year Est. Return

Schulhoff & Co's Q4 2025 Portfolio in Review

As of Q4 2025, Schulhoff & Co held 138 positions worth $238M, up 1.4% from $234M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Schulhoff & Co's Q4 2025 filing shows 3 new, 34 increased, 36 reduced and 6 closed positions. Its largest new stake was CytomX Therapeutics: 374,850 shares worth $1.6M. The largest sale was Avadel Pharmaceuticals, an estimated $2.1M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Consumer Staples and Industrials.

  • Schulhoff & Co's largest Q4 2025 buy was CytomX Therapeutics: 374,850 shares worth $1.6M.
  • Schulhoff & Co added most to Sprott Physical Silver Trust in Q4 2025, an estimated $566K increase.
  • Schulhoff & Co's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $452K.
  • Schulhoff & Co fully exited Avadel Pharmaceuticals in Q4 2025, selling an estimated $2.1M.
  • Schulhoff & Co's ten largest holdings make up 41% of its $238M portfolio in Q4 2025.
  • Schulhoff & Co opened 3 new positions and closed 6 in Q4 2025.
  • Schulhoff & Co's portfolio value rose 1.4% quarter-over-quarter to $238M.

Based on Schulhoff & Co's 13F filing for Q4 2025, filed 11 Feb 2026.